Business - Briefly   

Novo Nordisk's insulin for pregnant women

CHENNAI: Novo Nordisk announced that the European Commission has approved the rapid-acting insulin NovoRapid (insulin aspart) for use by pregnant women with diabetes. NovoRapid is a modern insulin that has a label stating it can be used in pregnancy, says a company release.

Printer friendly page  
Send this article to Friends by E-Mail

Stories in this Section

Suncity among 44 SEZs approved
Parsvnath to tap market
Dr. Reddy's posts Rs. 2,000 cr. sales in second quarter
Sensex spurts 208 points
JRG's net on the rise
New MD for MPIL
Manmohan to lay foundation for Rs. 95 crore project of KMML
Talks on for Travancore Rayons takeover by new promoter
Rehabilitation Plantation pays dividend
Corporation Bank's first half net up
Ashapura to build Kutch refinery
Rupee moves up further
Tax evasion cases against 3 major cos.
Inflation rate rises to 5.26 p.c.
Forex reserves up $1.20 b
SEBI withdraws facility
RBI directive to NBFCs
Sun TV second quarter net up 43 p.c.
MG Trident Tooling's facility in Chennai
Novo Nordisk's insulin for pregnant women
IIFC steps to deliver infrastructure projects
BEML Q2 net at Rs. 36 crore
Alchemist board proposes 1:1 bonus
BHEL bags Rs. 950 cr. order
Royal Orchid Hotels posts Rs. 6.68 cr. net

Copyright © 2006, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu